Dianthus therapeutics announces two poster presentations for dnth103 at the 2024 american association of neuromuscular and electrodiagnostic medicine (aanem) annual meeting

New york and waltham, mass., oct. 15, 2024 (globe newswire) -- dianthus therapeutics, inc. (nasdaq: dnth), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced two poster presentations for dnth103 at the 2024 american association of neuromuscular and electrodiagnostic medicine (aanem) annual meeting, taking place october 15-18, 2024 in savannah, georgia.
DNTH Ratings Summary
DNTH Quant Ranking